Trial Information
Inclusion Criteria:
- Histologically confirmed diagnosis of primary gastric cancer + histologically and/or
radiologically confirmed peritoneal carcinomatosis diagnosis
- Adequate renal-, hematopoietic- and liver functions
- WHO performance status (WHO) of < 2.
Exclusion Criteria:
- Distant metastases
- Surgically not resectable lymph-node metastasis
- Contraindication to chemotherapy treatment
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Overall survival
Outcome Time Frame:
Jan 2005 until Mars 2009
Safety Issue:
No
Authority:
Sweden: Socialstyrelsen
Study ID:
2007/073
NCT ID:
NCT01379482
Start Date:
January 2005
Completion Date:
March 2009
Related Keywords:
- Peritoneal Carcinomatosis
- Gastric Cancer
- Peritoneal carcinomatosis from gastric cancer
- Stomach Neoplasms
- Carcinoma